Oncology
Cancer clinical trials
Studies of cancers and tumors of every type and site, from prevention to treatment. We’re tracking 20,103 recruiting studies in this area right now.
By phase
- Not applicable9,481
- Phase 24,388
- Phase 12,656
- Phase 1/Phase 21,646
- Phase 31,390
- Phase 2/Phase 3282
- Phase 4260
Top conditions
- Breast Cancer1,192
- Prostate Cancer645
- Cancer633
- Colorectal Cancer480
- Lung Cancer415
- Ovarian Cancer336
- Multiple Myeloma327
- Pancreatic Cancer289
- Gastric Cancer283
- Acute Myeloid Leukemia281
- Hepatocellular Carcinoma256
- Solid Tumor245
- Advanced Solid Tumor236
- Head and Neck Cancer224
- Cervical Cancer223
- Endometrial Cancer206
- Advanced Solid Tumors198
- Esophageal Cancer189
Leading sponsors
- M.D. Anderson Cancer Center452
- Fudan University302
- National Cancer Institute (NCI)293
- Memorial Sloan Kettering Cancer Center291
- Sun Yat-sen University273
- Mayo Clinic237
- City of Hope Medical Center141
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences140
- AstraZeneca134
- Second Affiliated Hospital, Zhejiang University, School of Medicine128
Where studies are running
- California1,412
- Texas636
- Arizona514
- Florida429
- Alabama426
- New York407
- Massachusetts341
- Maryland332
- New Jersey269
- Pennsylvania234
Recruiting studies20,103 total
- NCT05043571RecruitingPhase 1
CAR T-cell therapy for relapsed T-cell leukemia
This early-phase trial tests a lab-made immune cell treatment (CAR T-cells) aimed at T-cell leukemia that has come back or did not respond. It may help by targeting leukemia cells with a specific marker (CD7), especially in patients who failed standard treatment.
SingaporeAges 6 months–65 years - NCT03463252RecruitingPhase 2/Phase 3
Hormone IUD to preserve fertility in early uterine cancer
This study looks at whether a hormone-releasing IUD (LNG-IUS) can treat early-stage endometrial cancer or very early abnormal cell growth while helping you keep the option for future pregnancy. It aims to see how well the treatment works and how it affects fertility-related outcomes.
Chengdu, SichuanAges Up to 40 years - NCT04910802RecruitingPhase 4
HPV vaccine with routine HPV screening for ages 22–26
This study looks at giving the HPV vaccine (Gardasil 9) to women while they go through Sweden’s routine HPV screening. It helps researchers understand how vaccine use alongside screening affects HPV infection and cervical cancer prevention.
StockholmAges 22–27 - NCT04746209RecruitingPhase 2
Blinatumomab after transplant for high-risk B-ALL patients
This trial tests blinatumomab, an immune therapy, in young people with B-cell acute lymphoblastic leukemia (B-ALL) after their transplant or when they are getting ready for transplant. The goal is to lower the chance of the leukemia coming back by targeting remaining leukemia cells.
Milwaukee, WisconsinAges Up to 25 years - NCT05040555Recruiting
Testing a new chemo plan for newly diagnosed high-burden lymphoma
This trial studies a specific treatment plan to see how well it works for adults with newly diagnosed non-Hodgkin lymphoma that has a high amount of disease. It may help by aiming to control lymphoma more effectively, especially when it is widespread.
Changchun, JilinAges 18–75 - NCT05055635RecruitingPhase 2
Proton radiation for anal cancer that came back after prior treatment
This trial studies a focused type of proton radiation (“pencil beam”) to treat anal cancer that has returned after you previously had radiation. It may help by aiming treatment more precisely and giving another chance at cure when doctors think it can still be treated.
Aarhus N, AarhusAges 18 years+ - NCT05053802RecruitingPhase 2
Microwave tumor ablation plus immunotherapy for multiple lung cancers
This Phase 2 trial studies whether combining microwave ablation (a procedure to destroy lung tumors) with an immune checkpoint inhibitor can control multiple early lung cancers safely. It also aims to see how well the immune treatment helps after ablation, in people whose cancers have not spread.
Shanghai, Shanghai MunicipalityAges 18–79 - NCT05057598Recruiting
Online study for women with breast cancer experiences
This study asks women with breast cancer to take part in an online, before-and-after research project. It may help researchers understand your experiences and improve support for people living with breast cancer, including those with relapse or spread to other parts of the body.
Milan, MIAges 18–90 - NCT03193892Recruiting
National registry for women with lymphangioleiomyomatosis
This trial is a national health registry that collects medical information from women with lymphangioleiomyomatosis (LAM), a rare lung condition. It helps researchers better understand who has LAM and what their health looks like over time.
Beijing, Beijing MunicipalityAges Any age - NCT04831437RecruitingPhase 2
Tested split-course chemo radiation for cervical cancer side effects
This Phase 2 trial looks at a “split” (hypo-fractionated) schedule of chemotherapy plus radiation for cervical cancer, followed by brachytherapy. It aims to see how well the treatment works and what side effects happen, especially toxicity.
TehranAges 18–85 - NCT04109755RecruitingPhase 2
Pembrolizumab plus radiation before surgery for rectal cancer
This trial tests whether giving pembrolizumab (an immunotherapy medicine) together with short-course radiation before surgery helps people with localized rectal cancer. It is mainly for tumors that are microsatellite stable (MSS).
GenevaAges 18 years+ - NCT04670029RecruitingPhase 3
Testing an APA program to improve outcomes in large B-cell lymphoma
This Phase 3 trial studies whether an APA program (an added supportive program during care) can improve event-free survival for people with diffuse large B-cell lymphoma. It may help by supporting patients during standard first-line treatment so they do better over time.
BesançonAges 65 years+ - NCT05062005RecruitingPhase 3
Tests two ways of treating locally advanced nasopharyngeal cancer
This phase 3 trial compares a standard treatment plan (CRT) versus a new approach (ICCRT) for people with locally advanced nasopharyngeal cancer, without spread to distant organs. It aims to see which plan works better and is safe for tumors in the head and neck area.
Guangzhou, GuangdongAges 18–65 - NCT04933669RecruitingPhase 2
Pre-surgery imatinib for high-risk stomach or gut GIST
This trial studies whether taking imatinib before surgery can shrink or control high-risk gastrointestinal stromal tumors (GIST). If you qualify, you would receive imatinib as “neoadjuvant” (before the operation) and then move on to planned surgery.
Hangzhou, ZhejiangAges 18–80 - NCT04769947Recruiting
Registry for CML patients in deep remission after stopping pills
This study keeps records of people with chronic-phase CML who stopped their targeted leukemia pills (TKIs) while in a very deep remission. Researchers want to understand outcomes after stopping treatment and how often remissions are maintained.
TurinAges 18 years+ - NCT05080010RecruitingPhase 3
Extra chemo after eye removal for high-risk retinoblastoma
This Phase 3 study tests whether giving chemotherapy after the eye has been removed can lower the chance of retinoblastoma coming back for children with high-risk disease. You may be screened if your child had one eye affected and meet the staging and treatment history requirements.
Guangzhou, GuangdongAges Any age - NCT05086614RecruitingPhase 3
Thymosin-alpha 1 after surgery for high-risk colon cancer
This trial looks at whether thymosin-alpha 1, an immune-support treatment, can help prevent colon cancer from coming back after surgery. It targets people with high-risk stage II or III colon cancer who have had the tumor removed.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT05059379RecruitingPhase 3
Different radiation fields after breast cancer surgery
This trial compares two ways of giving radiation to lymph node areas near the collarbone after surgery for invasive breast cancer. It aims to see which radiation approach works better and is safer for preventing cancer returning in these lymph nodes.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT04362046Recruiting
Fertility-friendly treatment for early uterine cancer or precancer
This trial studies whether removing an early, hormone-responsive uterine growth using a procedure through the cervix can keep fertility possible. It is for people under 40 with a specific low-risk uterine biopsy and MRI findings who have already tried hormone treatment.
Vancouver, British ColumbiaAges 19–39 - NCT04316364RecruitingPhase 3
New immunotherapy plus chemo for resectable lung cancer
This Phase 3 trial studies whether an immunotherapy drug (SHR-1316) added to standard chemotherapy helps people live longer or delay cancer returning after surgery. It focuses on people with resectable non-small cell lung cancer (NSCLC) that has not been treated before.
Beijing, Beijing MunicipalityAges 18–70 - NCT04519905Recruiting
Testing two ways of radiation in older esophagus cancer patients
This study compares a planned radiation approach given at the same time as other treatment for older adults with esophageal squamous cell carcinoma. It may help find a safer and more effective radiation schedule for people who are fit enough for treatment.
Nanjing, JiangsuAges 76 years+ - NCT01638676RecruitingPhase 1/Phase 2
Testing vemurafenib plus metformin for BRAF-mutated melanoma
This study tests whether adding metformin to vemurafenib can shrink advanced melanoma in people with a specific gene change (BRAF V600E). It’s an early-phase trial, so the main goal is to see if the combination is safe and whether it may work better than expected.
Louisville, KentuckyAges 18 years+ - NCT05049317Recruiting
Check urinary and sexual function after rectal cancer surgery
This study looks at how a specific rectal surgery (laparoscopic total mesorectum excision) affects urinary and sexual function after the operation. It may help patients by tracking what to expect and which factors relate to better recovery.
Wuhan, HubeiAges 18–70 - NCT05104788RecruitingPhase 2
Icotinib plus chemotherapy before surgery for EGFR lung cancer
This trial studies how well a targeted medicine (icotinib) combined with chemotherapy works before surgery for certain EGFR-mutated lung adenocarcinoma. The goal is to shrink or control the tumor and make surgery more effective.
BeijingAges 18–75
Common questions
- How many cancer clinical trials are recruiting?
- Clin2 is tracking 20,103 recruiting oncology studies from the U.S. registry right now, out of 29,584 we cover in this area in total.
- What does “Cancer” cover here?
- Studies of cancers and tumors of every type and site, from prevention to treatment. We group each study into cancer based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a cancer trial near me?
- Use the search to filter cancer studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Skin
- Blood & lymphatic
- Kidney & urinary
- Infections
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Eyes & vision
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.